Peptides help women navigate menopause and manage symptoms effectively because they offer a customizable approach based on individual symptoms and goals, while addressing multiple concerns at once
*In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
The end organs (workers) are the liver, stomach and fat (adipose) cells.[1] What do GHRH and GH do
It would take randomized, placebo-controlled trials in humans, ideally several, run in more than one country and by groups without a financial stake in the answer, measuring a pre-specified cognitive outcome rather than a grab-bag of secondary ones